Rosacea is a chronic skin diseases marked by persistent facial erythema, easy flushing, and the development of telangiectasia. Over time papules and pustules may appear as well. Several topical and systemic medications are used to treat rosacea, but these primarily address the inflammatory lesion component. Treatments for persistent facial erythema are limited, usually requiring pulsed-due… Read More
First Topical Agent for Facial Erythema of Rosacea Approved
Brimonidine topical gel 0.33% (Mirvaso, Galderma Laboratories) has been approved by the FDA for facial redness resulting from rosacea in adults aged 18 years or older In clinical testing, the alpha 2 adrenergic agonist brimonidine topical gel yielded significantly greater improvement in the facial redness of rosacea than vehicle gel, according to the company sponsor… Read More
